You are here

Emma Walmsley

GSK must continue to improve R&D, says CEO Walmsley

Pharmaforum

Tue, 11/12/19 - 10:07 am

GSK’s Walmsley backs #MeTooPay gender pay campaign

Pharmaforum

Wed, 10/2/19 - 07:36 pm

Microsoft nominates GSK CEO Walmsley to board

Yahoo/Reuters

Fri, 09/20/19 - 09:14 am

Emma Walmsley earns £1M pay rise in her first full year at GSK's helm — but £5.9M package still trails other Big Pharma CEOs

Endpoints

Wed, 03/13/19 - 10:23 am

CEO Emma Walmsley takes GlaxoSmithKline on a quest for identity

Stat

Mon, 01/28/19 - 10:08 am

GSK chief Emma Walmsley rounds out her top team with CFO pick — but performance lags

Endpoints

Tue, 08/7/18 - 11:26 am

Forget a consumer spinoff. GlaxoSmithKline is plotting a $525M cost-cutting drive instead

Fierce Pharma

Wed, 07/25/18 - 03:19 pm

GSK bets $300 million on genetics as CEO plays down break-up talk

Yahoo/Reuters

Wed, 07/25/18 - 09:25 am

Trump invites pharma heads to private dinner during London visit, a trip that’s inspiring tens of thousands to protest

Endpoints

Thu, 07/5/18 - 11:22 am

GSK’s high-level management makeover continues as CEO Emma Walmsley oversees changing of the guard

Endpoints

Tue, 06/12/18 - 09:57 am

GSK boss rethinking R&D incentives, as Barron and Sin seek out early and late-stage ops

Fierce Biotech

Wed, 04/25/18 - 01:07 pm

First assessment of radical reorganization imposed by GSK new CEO Emma Walmsley

GoinPharma

Mon, 03/26/18 - 12:30 pm

Glaxo's Boss Looks Ready to Loosen the Straitjacket

Bloomberg

Fri, 03/23/18 - 09:57 am

consumer health

GlaxoSmithKline chief Emma Walmsley nets $6.8M in pay in her first year at the helm

Fierce Pharma

Thu, 03/15/18 - 09:40 pm

No more Mr Nice Guy: GlaxoSmithKline is coming out of its corner swinging

Endpoints

Thu, 02/8/18 - 11:18 am

Gilead Sciences

JPM18: GSK's Walmsley weighs in on Pfizer, gender diversity

Biopharma Dive

Wed, 01/10/18 - 06:53 pm

gender diversity

GSK lines up a shot at a blockbuster market as new CEO prepares to tackle Merck rival head on

Endpoints

Thu, 09/14/17 - 09:54 am

GSK déjà vu: Time for a top-down switch as new CEO tries to conquer old R&D demons

Endpoints

Mon, 08/7/17 - 11:14 am

GSK CEO Walmsley is reorganizing R&D, dropping drugs and adding a new focus on cancer research

Endpoints

Wed, 07/26/17 - 09:52 am

GlaxoSmithKline's New CEO Is Off to a Good Start

Motley Fool

Mon, 05/29/17 - 11:54 am

Pages